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GYNECOLOGY
Risk of reoperation 10 years after surgical treatment for
stress urinary incontinence: a national
population-based cohort study
Patrick Muller, MSc; Ipek Gurol-Urganci, PhD; Jan van der Meulen, PhD; Ranee Thakar, MD; Swati Jha, MD
BACKGROUND: There is a debate about the safety and effectiveness
of surgical treatments for stress urinary incontinence. Controversy about
the use of synthetic mesh sling insertion has led to an increased uptake of
retropubic colposuspension and autologous sling procedures. Compara-
tive evidence on the long-term outcomes from these procedures is
needed.
OBJECTIVE: To compare the risk of reoperation at 10 years after
operation between women treated for stress urinary incontinence with
retropubic colposuspension, mesh sling insertion, and autologous sling
procedures.
STUDY DESIGN: The records of admissions to National Health
Service hosptials were used to identify women who had first-time stress
incontinence surgery between 2006 and 2013 in England. The first
incidence of the following outcomes was assessed: further stress in-
continence surgery, surgery for a complication (either mesh removal,
prolapse repair, or incisional hernia repair), and any reoperation (either
further stress incontinence surgery, mesh removal, prolapse repair, or
incisional hernia repair). The cumulative incidence of each of these
outcomes up to 10 years after surgery was calculated, considering
death as a competing event. Multivariable modeling was then used to
estimate the reoperation hazard ratios for the different initial surgery
types with adjustments for patient characteristics and concurrent pro-
lapse surgery or hysterectomy.
RESULTS: The analysis included 2262 women treated with retropubic
colposuspension, 92,524 treated with mesh sling insertion, and 1234
treated with autologous sling. The cumulative incidence of any first
reoperation at 10 years was 21.3% (95% confidence interval, 19.5e23.0)
after retropubic colposuspension, 10.9% (10.7e11.1) after mesh sling
insertion, and 12.0% (10.2e13.9) after autologous sling procedures. The
women who had a retropubic colposuspension were significantly more
likely to have a reoperation than women who had an autologous sling
(adjusted hazard ratio for any reoperation: 1.79 [1.47e2.17]; for further
stress incontinence surgery: 1.64 [1.19e2.26]; for surgery for compli-
cations: 1.89 [1.49e2.40]), whereas the women who had mesh slings
had a similar hazard (for any reoperation: 0.90 [0.76e1.07]; for further
stress incontinence surgery: 0.75 [0.57e0.99]; for surgery for compli-
cations: 1.11 [0.89e1.36]). A sensitivity analysis excluding the women
who had concurrent prolapse surgery or hysterectomy produced similar
results.
CONCLUSION: Retropubic colposuspension is associated with higher
risk of reoperation at 10 years after surgery than mesh sling insertion or
autologous sling procedures, with 1 in 5 women requiring reoperation.
Key words: adverse events, autologous sling, complications, fascial
sling, hernia repair, incontinence surgery, mesh removal, pelvic organ
prolapse, retropubic coloposuspension, synthetic mesh sling
Introduction
Since its introduction in 1998, synthetic
mesh sling insertion has been the treat-
ment of choice for stress urinary incon-
tinence (SUI) in many countries.
However, reports of severe adverse
events following this treatment has led to
a controversy about its use.1 Some
women treated with mesh slings have
experienced pain, dyspareunia, persis-
tent incontinence, andmesh exposure.2,3
In England, the volume of patients
treated with mesh slings fell from 11,000
in October 2009 to 4000 in 2017/18 in
response to reports of adverse out-
comes.4 This has resulted in an increased
uptake of alternative surgical procedures
for SUI, such as retropubic colposus-
pension and autologous sling procedures
(insertion of slings harvested from the
patient’s own fascia), which previously
were gold standard treatments.5,6
A systematic review of the evidence
from randomized controlled trials
(RCTs) published in 2019 reported
comparable effectiveness at the medium
term between retropubic colposus-
pension, mesh sling insertion, and
autologous sling procedures, and no
evidence of increased adverse events
with mesh slings.7 However, the authors
of that review cautioned that sparse data
were available on effectiveness and
adverse events beyond 1 year. The need
for better data on the long-term safety
and effectiveness of the surgical proced-
ures used for SUI was also highlighted in
a report from the Independent Medi-
cines and Medical Devices Review in the
United Kingdom published in 2020.4
Several recent studies have used
population-based datasets to assess the
long-term outcomes following SUI
treatment with a mesh sling insertion. A
study of 95,000 women in England re-
ported that at 9 years after mesh sling
insertion, 3.3% ofwomen hadmesh rem-
oval and 6.9% either had removal or
further SUI surgery.8 A study of 17,000
women in Scotland compared the post-
operative complications, further SUI
surgery, and further prolapse surgery
between different SUI surgeries.9 That
study reported considerably lower risks of
immediate complications and prolapse
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surgery at 5 years with mesh sling inser-
tion than with open retropubic colpo-
suspension, and a comparable risk of
further SUI surgery and long-term com-
plications at 5 years. In contrast, a study of
155,000 women in the United States re-
ported that by 9 years of follow-up, the
cumulative incidence of further SUI sur-
gery was higher among the women
treated with mesh or autologous sling
insertion than the women treated with
retropubic colposuspension.10
This study aimed to estimate the risk
of reoperation associated with different
types of SUI surgery, including retro-
pubic colposuspension, mesh sling
insertion, and autologous sling proced-
ures, up to 10 years after surgery, using
administrative hospital data on all the
women who had first-time SUI surgery
in the English National Health Service
(NHS) between 2006 and 2013. We also
assessed the risk of specific reoperation
types, including further SUI surgery,




Data on all the admissions to NHS hos-
pitals in England from April 2002
to March 2019 were extracted from
Hospital Episodes Statistics (HES), an
administrative database of all care epi-
sodes in the NHS hospitals in England,
with records including patient
demographics, dates of admission and
discharge, diagnostic and procedure in-
formation, and date of death. The NHS
hospitals are reimbursed according to
the clinical activity recorded in the HES
database, so the completeness is ex-
pected to be high.11 The surgical pro-
cedures for SUI were identified using the
Office for Population Censuses and
Surveys Classification of Interventions
and Procedures Version 4 (OPCS-4)
codes (full OPCS-4 code list in
Supplemental Table 1).12 Urethral bulk-
ing agents were excluded, as they are not
a surgical procedure and are not ex-
pected to provide long-term cure for
stress incontinence.
Cohort selection and outcome
definition
All women who had a first-time treat-
ment for SUI with retropubic colposus-
pension (abdominal or laparoscopic), a
mesh sling insertion, or an autologous
sling procedure between April 1, 2006
and March 31, 2013 were eligible for
inclusion. The start of the inclusion
period was chosen as mesh-specific
OPCS-4 codes only became available in
2006, and the end was chosen to allow at
least 6 years of follow-up for each pa-
tient. The mesh sling cohort included
women who had a retropubic or trans-
obturator midurethral sling (excluding
single incision slings) and the autologous
sling cohort included women with
treatment codes for suprapubic sling and
abdominoperineal suspension of the
urethra (full OPCS-4 code list in
Supplemental Table 1). A concurrent
hysterectomy at the time of the initial
SUI surgery was defined as the presence
of an OPCS-4 code starting with “Q07”
(abdominal hysterectomy) or “Q08”
(vaginal hysterectomy). A concurrent
prolapse repair was defined as the pres-
ence of any OPCS-4 code for prolapse
repair (full OPCS-4 code list in
Supplemental Table 2).
Women were excluded from the
cohort if an SUI treatment code (any of
the SUI treatments considered in this
study, or a record of unspecified SUI
surgery [“M53.9”] or urethral bulking
agents [“M56.3”]) was included in the
record of a hospital admission in the 3
years immediately before surgery. If a
patient had a first nonmesh procedure
but then went on to have an admission
wheremesh removal was recorded, it was
assumed that the nonmesh procedure
was an incorrectly recorded surgery with
mesh, and the patient was included in
the mesh sling insertion group.
The reoperations considered included
mesh removal, further SUI surgery,
prolapse surgery, and incisional hernia
surgery (full OPCS-4 code list in
Supplemental Table 2). Further SUI
surgery indicates the recurrence of in-
continence symptoms, whereas the other
3 surgeries may be required to treat
complications of the initial procedure.
Specifically, the risk of hernia is
increased with open surgery and
following autologous sling procedures
owing to aweakness in the support of the
anterior abdominal wall resulting from
the removal of a piece of the rectus.
For the time-to-event analyses, the
primary outcome was defined as the
time from first-time SUI surgery to
the first occurrence of any of the reop-
erations. If a patient had 2 of the
different reoperations on the same day,
the reoperation type was categorized as
the first in the following sequence: mesh
removal, further SUI surgery, prolapse
surgery, hernia repair. This order was
chosen to ensure that all the mesh re-
movals were included in the results for
the reoperation type. Two secondary
AJOG at a Glance
Why was this study conducted?
Reviews have highlighted a need for comparative evidence on the long-term
outcomes following the different surgical treatment options for stress urinary
incontinence.
Key findings
Retropubic colposuspension is associated with a higher risk of reoperation than
mesh sling insertion and autologous sling procedures, with one in 5 women
requiring reoperation within 10 years of the initial surgery.
What does this add to what is known?
This study follows up women who had surgery for stress urinary incontinence to
10 years postsurgery, which is longer than any previous large study. We found
differences in the reoperation risk between retropubic colposuspension andmesh
and autologous sling procedures, which increased between 5 and 10 years of
follow-up.
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outcomes that were analyzed included
the time to the first further stress in-
continence surgery and the time to the
first surgery for a complication (either
mesh removal, prolapse repair, or inci-
sional hernia repair), in each case, with
the other event type ignored and death
considered the only competing event.
A woman’s ethnicity was retrieved
from the record of the admission during
which the SUI surgery took place. If the
ethnicity information was not available
in that record but was available in
another HES record, the information
from that record was used instead. The
Index of Multiple Deprivation (IMD), a
score covering an area with a typical
population of 1500 people, was grouped
into quintiles according to the national
distribution and used to measure socio-
economic deprivation status.13 The
number of preexisting comorbid condi-
tions at the time of surgery was gener-
ated using the algorithm developed by
the Royal College of Surgeons of En-
gland14 and was applied to the records of
the admission with the SUI surgery and
all admissions in the 3 preceding years.
Statistical methods
We estimated the cumulative incidence
of any first reoperation (either of further
SUI surgery or surgery for a complica-
tion) up to 10 years after the SUI surgery,
considering death as a competing event.
Follow-up for each woman ended at the
first reoperation, at the end of the study
period (March 31, 2019), after 10 years
of follow-up, or death; whichever
happened first. The cumulative inci-
dence estimates were also produced for
the other 2 outcomes of the first further
SUI surgery and the first surgery for a
complication.
The estimates of the cumulative inci-
dence of any first reoperation were
broken down according to the reopera-
tion type. This was done by estimating
the risk of each type of reoperation at
each day of follow-up, considering only
those patients who were not already
censored, dead, or reoperated as being at
risk on that day and then summing the
estimated risks of each reoperation type
at each day to generate the cumulative
incidence of each type up to 10 years.
The results are interpretable as the per-
centage of women who had each first
reoperation type by 10 years of follow-
up, where other potential outcomes
were death or the occurrence of another
reoperation first.
Fine-Gray competing risks regression
models were used to estimate the risk-
adjusted subdistribution hazard ratios
(HRs), representing the relative differ-
ences in the incidence rates of the first
reoperations between the 3 types of SUI
surgery. The HRs were adjusted for dif-
ferences between the surgery groups in
age, socioeconomic deprivation, num-
ber of preexisting comorbidities,
ethnicity, year of operation, and con-
current prolapse surgery or hysterec-
tomy (divided into abdominal or
vaginal).15 The HRs estimated by the
model can be interpreted as a measure of
relative risk; a value of 1 implies no dif-
ference, a value >1 indicates an
increased incidence compared with the
reference, and a value <1 indicates a
decreased incidence. Autologous sling
was used as the reference category for
estimates of HRs between the surgery
types. A P value smaller than .05 was
considered to indicate a statistically sig-
nificant result.
One sensitivity analysis was done for
the outcome of any reoperation as fol-
lows: the HRs were calculated only
including the womenwho did not have a
concurrent hysterectomy or prolapse
surgery at time of the initial SUI surgery
to assess for confounding from the
differences in the frequency of these




The records from a total of 96,020
women were analyzed, including 2262
who had a retropubic colposuspension,
92,524 who had a mesh sling insertion,
and 1234 who had treatment with an
autologous sling procedure. Most of the
women were aged between 40 and 60
years at the time of the initial SUI surgery
(Table 1). The groups of women
receiving different types of SUI surgery
were similar with respect to socioeco-
nomic deprivation status, preexisting
comorbidities, and ethnicity. A concur-
rent hysterectomy was more often car-
ried out in women who had retropubic
colposuspension (21.9%) than in
women who had a mesh sling insertion
(5.7%) or an autologous sling procedure
(3.5%). Concurrent prolapse surgery
was less frequently carried out in women
who had an autologous sling procedure
(8.6%) than in women who had a mesh
sling insertion (16.9%) or retropubic
colposuspension (17.1%).
The average time that women were
followed-up to, defined as the time from
SUI surgery to death or the end of
follow-up, was 9.8 years for women
treated with retropubic colposus-
pension, compared with 8.8 years for
women treated with a mesh sling inser-
tion, and 9.6 years for women treated
with an autologous sling procedure.
Time-to-event results
There were stark differences in the cu-
mulative incidence of any first reopera-
tion at 10 years betweenwomenwho had
different types of SUI surgery as follows:
21.3% (95% confidence interval [CI],
19.5e23.0) for the women who had
retropubic colposuspension, compared
with 10.9% (95% CI, 10.7e11.1) for the
women who had a mesh sling insertion,
and 12.0% (95% CI, 10.2e13.9) for the
women who had an autologous sling
procedure (Table 2, Figure). Although
mesh sling insertion and autologous
sling procedures were associated with a
similar incidence of any first reopera-
tion, the types were different. Compared
with the women who had an autologous
sling procedure, the women who had a
mesh sling insertion were at risk of
having mesh removal (3.0% compared
with 0.0%), but they had a lower inci-
dence of further surgery for SUI (2.6%
compared with 4.5%), hernia repair
(0.7% compared with 1.9%), and pro-
lapse surgery (4.6% compared with
5.5%).
In the analysis of the first surgery for a
complication where further incontinence
surgery was not considered as a
competing event, the 10-year incidence
was 15.6% (14.1%e17.2%) for women
treated with retropubic colposuspension,
compared with 8.8% (8.6%e8.9%)
ajog.org GYNECOLOGY Original Research
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for women treated with mesh sling
insertion, and 7.8% (6.3%e9.4%) for
women who had an autologous sling
procedure (Supplemental Table 3). In the
equivalent analysis of first further SUI
surgery, the 10-year incidence was 7.6%
(6.5%e8.8%) for women treated with
retropubic colposuspension, compared
with 3.5% (3.3%e3.6%) for womenwho
had a mesh sling insertion, and 4.8%
(3.7%e6.2%) for women who had
autologous sling procedures.
In the fully adjusted model for the
hazard of any first reoperation,
compared with women who had an
autologous sling procedure, womenwho
had a retropubic colposuspension had a
considerably higher hazard (adjusted
TABLE 1










Yes 386 (17.1) 15,627 (16.9) 106 (8.6)
No 1876 (82.9) 76,897 (83.1) 1128 (91.4)
Concurrent hysterectomy
Yes 495 (21.9) 5234 (5.7) 43 (3.5)
No 1767 (78.1) 87,290 (94.3) 1191 (96.5)
Age group (y)
18e39 288 (12.7) 9687 (10.5) 150 (12.2)
40e49 814 (36.0) 31,390 (33.9) 371 (30.1)
50e59 544 (24.0) 23,777 (25.7) 314 (25.4)
60e69 412 (18.2) 17,181 (18.6) 230 (18.6)
70 202 (8.9) 10,484 (11.3) 161 (13.0)
Missing 2 (0.1) 5 (0.0) 8 (0.6)
Deprivation quintilea
1 Most deprived 386 (17.1) 15,264 (16.5) 233 (18.9)
2 406 (17.9) 17,562 (19.0) 276 (22.4)
3 436 (19.3) 19,518 (21.1) 261 (21.2)
4 504 (22.3) 20,066 (21.7) 243 (19.7)
5 Least deprived 512 (22.6) 19,727 (21.3) 215 (17.4)
Missing 18 (0.8) 387 (0.4) 6 (0.5)
Number of comorbid conditions
0 1743 (77.1) 72,016 (77.8) 921 (74.6)
1 444 (19.6) 17,085 (18.5) 251 (20.3)
2 59 (2.6) 2779 (3.0) 42 (3.4)
3þ 16 (0.7) 644 (0.7) 20 (1.6)
Missing 0 (0.0) 0 (0.0) 0 (0.0)
Ethnicity
White 2078 (91.9) 86,143 (93.1) 1168 (94.7)
Asian or Asian British 54 (2.4) 2086 (2.3) 25 (2.0)
Black or Black British 39 (1.7) 747 (0.8) 9 (0.7)
Other 45 (2.0) 1356 (1.5) 13 (1.1)
Missing 46 (2.0) 2192 (2.4) 19 (1.5)
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ratio, 1.79 [1.47e2.17]), whereas
women who had mesh slings had a
similar hazard (0.90 [0.76e1.07];
Table 3). In the adjusted model for the
first surgery for a complication where
further incontinence surgery was not
treated as a competing event, retropubic
colposuspension was associated with
higher hazard (1.89 [1.49e2.40])
whereas mesh sling insertion was asso-
ciated with similar hazard (1.10
[0.90e1.36]). In the equivalent model
for the first further stress incontinence
surgery, women treated with retropubic
colposuspension had a higher hazard
(1.78 [1.31e2.42]), and there was weak
evidence to show that women treated
with a mesh sling had a lower hazard
(0.79 [0.60e1.03]).
A sensitivity analysis including only
the 76,903 women who did not have a
concurrent prolapse repair or hysterec-
tomy at the time of initial SUI surgery
returned very similar results
(Supplemental Tables 4 and 5). The 10-
year cumulative incidence of any reop-
eration was 19.9% (17.9%e22.2%) for
women who had retropubic colposus-
pension, 9.8% (9.6%e10.1%) for
women who had a mesh sling insertion,
and 11.1% (9.3%e13.2%) for women
who had an autologous sling procedure.
In the modeling sensitivity analysis, the
adjusted hazard ratio for reoperation for
women who had retropubic colposus-
pension was 1.91 (1.53e2.38) and for




Women treated with retropubic colpo-
suspension had nearly double the risk of
any reoperation in the first 10 years after
SUI surgery, compared with the women
treated with a mesh sling insertion or an
autologous sling procedure. Concurrent
abdominal or vaginal hysterectomy or
prolapse surgery alongside the initial SUI
surgery were associated with an increased
risk of reoperation. Women who had
retropubic colposuspension were most
likely to have one of these concurrent
surgical procedures. However, this did
not explain the higher reoperation rates; a
sensitivity analysis including only women
who did not have concurrent procedures
returned similar results.
Mesh sling insertion and autologous
sling procedures were associated with a
similar overall risk of reoperation. The
reoperation types, however, were
different. Women who had mesh slings
were at risk of having mesh removal but
had a lower risk of further SUI surgery,
hernia repair, and prolapse surgery.
Results in the context of what is
known
Our finding of a 10-year cumulative
incidence of further SUI surgery of
21.3% with retropubic colposuspension
compared with 10.9% with a mesh sling
insertion indicates a greater difference in
long-term safety and effectiveness than
has previously been reported. For
example, a recent systematic review
published in 2019 found no evidence of
differences between mesh slings and
retropubic colposuspension, but it
concluded that there was a lack of data
on long-term effectiveness and adverse
outcomes.7
The population-based study in Scot-
land by Morling et al9 found that read-
missions for further SUI surgery by 5
years were slightly higher for women
treated with retropubic colposuspension
(6%) than with mesh (4% for retropubic
and 5% for transobturator slings). We
report a greater difference in the 10-year
incidence of further stress incontinence
surgery at 7.6% with retropubic colpo-
suspension compared with 3.5% with
mesh sling insertion, which is especially
relevant for younger women undergoing
first-time SUI surgery. In contrast to our
study and the one in Scotland and ameta
analysis published in 2019,7 the
population-based study in the United
TABLE 1










2006 445 (19.7) 5578 (6.0) 297 (24.1)
2007 396 (17.5) 12,215 (13.2) 214 (17.3)
2008 347 (15.3) 13,560 (14.7) 155 (12.6)
2009 288 (12.7) 13,289 (14.4) 114 (9.2)
2010 246 (10.9) 12,778 (13.8) 101 (8.2)
2011 198 (8.8) 12,349 (13.3) 104 (8.4)
2012 173 (7.6) 11,610 (12.5) 124 (10.0)
2013 169 (7.5) 11,145 (12.0) 125 (10.1)
Missing 0 (0.0) 0 (0.0) 0 (0.0)
a Ecological measure of the socioeconomic status, based on the national distribution of the Index of Multiple Deprivation ranking of the patient’s local area of residence.
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States by Jonsson Funk et al10 reported a
higher overall incidence of further stress
incontinence surgery at 9 years follow-
up with every initial surgery type, and a
lower risk at 9 years follow-up with ret-
ropubic colposuspension (10.8%)
compared with mesh sling insertion
(13.0%). As that study evaluated women
with specific private medical insurance
plans up to age 65 years only in the
period from 2000 to 2009, the different
findings may be partly attributable to the
differences in surgeon experience with
mesh sling insertion (which was
introduced from 1997) at that time and
the patient population analyzed.
Our results are in line with other
studies that compared the rates of pro-
lapse surgery following retropubic col-
posuspension and mesh slings, though
ours is the only study to report the cu-
mulative incidence of these procedures
over a follow-up period of 10 years. The
Scottish population-based study re-
ported that 7% of the women treated
with retropubic colposuspension and
2% of the women treated with mesh
slings had further prolapse surgery
within 5 years, compared with 11.9%
and 4.6%, respectively, within 10 years in
our analysis.9 An RCT comparing mesh
sling insertion with retropubic colpo-
suspension reported that 7.5% of
women in the retropubic colposus-
pension arm and 1.8% of women in the
mesh sling arm were readmitted for
prolapse surgery by 5 years.16 This dif-
ference in an RCTsetting underlines that
the increased prolapse risk associated
with retropubic colposuspension can be
directly attributed to the initial surgery
and not to any residual case-mix
TABLE 2
Cumulative incidence of any first reoperation (95% confidence interval) following stress urinary incontinence surgery
by initial surgery type, broken out by reoperation done (2006e2013)
Number of patients at risk Retropubic colposuspension Mesh sling insertion Autologous sling
Total cohort 2262 92,524 1234
At 1 y 2160 89,500 1191
At 5 y 1866 83,460 1089
At 10 y 951 28,483 559
Cumulative incidence of first reoperations (of any type)
At 1 y 4.2 (3.4e5.1) 3.1 (2.9e3.2) 2.7 (1.9e3.7)
At 5 y 16.0 (14.4e17.4) 7.8 (7.6e7.9) 8.7 (7.2e10.3)
At 10 y 21.3 (19.5e23.0) 10.9 (10.7e11.1) 12.0 (10.2e13.9)
Distribution of first reoperation types at 1 y
Mesh removal 0 1.3 0.0
Further stress incontinence surgery 1.6 1.0 1.8
Prolapse surgery 2.4 0.8 0.4
Hernia repair 0.2 0.1 0.5
Total 4.2 3.1 2.7
Distribution of first reoperation types at 5 y
Mesh removal 0 2.4 0.0
Further stress incontinence surgery 5.4 2.1 3.8
Prolapse surgery 8.9 2.9 3.5
Hernia repair 1.6 0.4 1.3
Total 16.0 7.8 8.7
Distribution of first reoperation types at 10 y
Mesh removal 0.0 3.0 0.0
Further stress incontinence surgery 7.1 2.6 4.5
Prolapse surgery 11.9 4.6 5.5
Hernia repair 2.3 0.7 1.9
Total 21.3 10.9 12.0
Data are presented as percentage.
Muller et al. Reoperation risk following stress urinary incontinence surgery. Am J Obstet Gynecol 2021.
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differences. The higher risk is likely to be
attributable to the disruption of the
vaginal axis leaving the posterior wall of
the vagina under pressure or to an
intrinsic weakness of the pelvic floor in
these women.
Strengths and limitations
A key strength of this study is that it is
based on a national population-based
cohort of all the women who received
SUI surgical treatment in the NHS in
England between 2006 and 2013 and
who were followed-up until March 31,
2019. Less than 5% of healthcare
expenditure in England covers treatment
outside the NHS, so the cohort is highly
representative of the whole popula-
tion.17 The study outcome of reopera-
tion within the NHS is expected to be
near 100% complete for the same
reason. We analyzed patients up to 10
years after their operation, a longer
period than any previous large study,
which fills the evidence gap on long-
term outcomes.7,18
Another strength is that we estimated
the cumulative incidence of the first
reoperations by the reoperation type.
These results illustrate the impact of
higher rates of prolapse surgery and
further SUI surgery after retropubic
colposuspension on the overall risk of
reoperation at 10 years. The statistics we
report can be readily interpreted by pa-
tients and clinicians as the long-term risk
of specific first reoperations following
SUI surgery.
A limitation of our study is that we
had no data on the patient-reported
outcomes, which would have given
further information about the nature
and the severity of adverse outcomes
after SUI surgery. Moreover, we had no
details of the immediate intra- and
postoperative complications or on the
need for self-catherization. For 3 of the
reoperation types (ie, further SUI sur-
gery for persistent or recurrent incon-
tinence, prolapse operation, or
incisional hernia repair), the specific
surgical procedure indicates the nature
of problems treated. Mesh removal,
however, can be done in response to the
various adverse events known to be
associated with a mesh sling insertion,
but the indication for removal is not
deducible in this study. In addition, it is
likely that reoperations were only car-
ried out if the problem was severe. So
the cumulative incidence of reopera-
tions underestimates the frequency of
adverse outcomes after SUI surgery
across the full spectrum of severity, as
many women would choose not to have
reoperations and cope with their
problems.
Finally, the patients who had different
types of SUI surgery may have had
different characteristics that are associ-
ated with reoperation risk, which were
not included in the risk adjustment in
our models. However, given the
observed risk of reoperation after a ret-
ropubic colposuspension is considerably
higher than after mesh sling insertion or
an autologous sling procedure, it is very
unlikely that residual confounding can
explain the difference.
Clinical and research implications
The decrease in the use of synthetic
mesh sling insertion for continence
surgery in many countries has resulted
in an increase in nonmesh surgery (ie,
retropubic colposuspension and autol-
ogous sling procedures).4 It is impor-
tant that the patients considering
surgery are made aware of the evidence
on the risks and benefits from each of
these treatments. However, thus far,
there have been sparse comparative data
on the long-term outcomes. This study
provides robust evidence that can be
used to counsel women considering
surgery.
Women considering surgery should be
informed that the 10-year risk of surgery
for mesh removal following synthetic
sling insertion is approximately 3%,
whereas the risk of reoperation for pro-
lapse repair following retropubic colpo-
suspension is over 10%. They should also
be informed that the overall reoperation
risk following retropubic colposus-
pension at approximately 20% is twice as
high as the risk following surgery with
synthetic or autologous slings.
The difference in the reoperation
rates between the different SUI sur-
geries we report does not by itself
support a restriction on the use of mesh
slings, such as the pause on the routine
use of them with the NHS in England
FIGURE
Cumulative incidence of reoperations up to 10 years by initial stress urinary
incontinence surgery type, England, 2006 to 2013
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TABLE 3
Fine-Gray model estimates of the reoperation hazard by the type of initial stress urinary incontinence surgery done for










first surgery for a
complication (95% CI)
Operation type
Autologous sling 1.00 1.00 1.00
Retropubic colposuspension 1.79 (1.47e2.17) 1.78 (1.31e2.42) 1.89 (1.49e2.40)
Mesh sling insertion 0.90 (0.76e1.07) 0.79 (0.60e1.03) 1.10 (0.90e1.36)
Concurrent prolapse repair
No 1.00 1.00 1.05 (0.96e1.14)
Yes 1.63 (1.55e1.71) 0.94 (0.85e1.03) 1.05 (0.96e1.14)
Concurrent hysterectomy
None 1.00 1.00 1.00
Abdominal hysterectomy 1.08 (0.90e1.29) 0.56 (0.38e0.81) 1.37 (1.13e1.65)
Vaginal hysterectomy 1.09 (1.00e1.19) 0.71 (0.59e0.87) 1.18 (1.08e1.30)
Operation year
2006 1.00 1.00 1.00
2007 1.05 (0.96e1.14) 1.09 (0.94e1.25) 1.05 (0.95e1.15)
2008 0.96 (0.89e1.05) 0.94 (0.81e1.08) 1.01 (0.91e1.11)
2009 0.89 (0.81e0.97) 0.77 (0.66e0.89) 0.94 (0.85e1.03)
2010 0.85 (0.78e0.93) 0.68 (0.58e0.79) 0.90 (0.81e1.00)
2011 0.85 (0.78e0.93) 0.65 (0.56e0.76) 0.94 (0.84e1.04)
2012 0.78 (0.71e0.86) 0.65 (0.55e0.76) 0.83 (0.74e0.92)
2013 0.75 (0.68e0.83) 0.58 (0.49e0.69) 0.84 (0.75e0.94)
Age group (y)
18e39 1.00 1.00 1.00
40e49 0.95 (0.88e1.01) 0.84 (0.75e0.95) 0.99 (0.92e1.07)
50e59 0.89 (0.83e0.96) 0.72 (0.64e0.81) 0.94 (0.87e1.02)
60e69 0.91 (0.84e0.98) 0.77 (0.68e0.88) 0.92 (0.85e1.00)
70 0.77 (0.70e0.84) 0.80 (0.69e0.92) 0.69 (0.62e0.77)
Deprivation quintile,a n (%)
1 Most deprived 1.00 1.00 1.00
2 1.03 (0.96e1.10) 1.03 (0.92e1.15) 1.05 (0.97e1.12)
3 0.96 (0.90e1.02) 0.98 (0.87e1.09) 0.96 (0.89e1.03)
4 0.96 (0.90e1.02) 1.01 (0.91e1.13) 0.97 (0.90e1.04)
5 least deprived 0.94 (0.88e1.00) 0.87 (0.78e0.98) 0.96 (0.90e1.04)
Charlson score
0 1.00 1.00 1.00
1 1.04 (0.98e1.09) 1.05 (0.96e1.15) 1.04 (0.98e1.10)
2 1.15 (1.02e1.29) 1.15 (0.94e1.40) 1.13 (0.99e1.29)
3þ 1.24 (0.98e1.56) 1.68 (1.19e2.36) 1.09 (0.83e1.44)
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that has been in place since 2018.
However, there is a need for long-term
data from patient-reported outcomes
following mesh and nonmesh surgeries
to fully understand the relative long-
term risks and benefits from these
different procedures.
Conclusion
Women considering surgical treatment
for SUI should be provided with robust
information on its long-term effective-
ness and the risk of adverse events. One
in 5 women treated with retropubic
colposuspension require reoperation
within 10 years, whereas mesh sling
insertion and autologous sling proced-
ures are associated with considerably
lower overall risk. However, the severity
of the conditions leading to reoperation
may be different between these 3 pro-
cedures, and long-term patient-reported
outcome data are needed to give a
complete picture of the risks and benefits
associated with each procedure. n
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Appendix
SUPPLEMENTAL TABLE 1
Office for Population Censuses and Surveys Classification of Interventions and Procedures Version-4 codes used to
identify surgical treatments for stress urinary incontinence
Code Description Surgery group
M53.3 Introduction of tension-free vaginal tape Mesh sling insertion
M53.6 Introduction of transobturator tape Mesh sling insertion
M52.1 Suprapubic sling operation Autologous sling
M51.1 Abdominoperineal suspension of urethra Autologous sling
M52.3 Colposuspension of neck of bladder Retropubic colposuspension
Muller et al. Reoperation risk following stress urinary incontinence surgery. Am J Obstet Gynecol 2021.
SUPPLEMENTAL TABLE 2
Office for Population Censuses and Surveys Classification of Interventions and Procedures Version-4 codes used to
identify mesh removal, prolapse surgery, further stress urinary incontinence surgery, and hernia repair
Code Description (Re-)operation type
M53.4 Total removal of tension-free vaginal tape Mesh removal
M53.5 Partial removal of tension-free vaginal tape Mesh removal
M53.7 Removal of transobturator tape Mesh removal
M53.8 þ Y03.7 Total or partial removal of tension-free vaginal tape Mesh removal
M57.4 Partial removal of transobturator tape Mesh removal
P18.1 Complete colpocleisis Prolapse surgery
P18.2 Partial colpocleisis Prolapse surgery
P23.2 Anterior colporrhaphy NEC Prolapse surgery
P23.3 Posterior colporrhaphy NEC Prolapse surgery
P23.4 Repair of enterocele NEC Prolapse surgery
P23.5 Paravaginal repair Prolapse surgery
P23.6 Anterior colporrhaphy with mesh reinforcement Prolapse surgery
P23.7 Posterior colporrhaphy with mesh reinforcement Prolapse surgery
P23.8 Other specified repair of prolapse of vagina Prolapse surgery
P24.2 Sacrocolpopexy Prolapse surgery
P24.4 Repair of vault of vagina using vaginal approach NEC Prolapse surgery
P24.6 Repair of vault of vagina with mesh using vaginal
approach
Prolapse surgery
P24.7 Sacrospinous fixation of vagina Prolapse surgery
P24.5 Repair of vault of vagina with mesh using abdominal
approach
Prolapse surgery
Q54.4 Suspension of uterus using mesh NEC Prolapse surgery
Q54.5 Sacrohysteropexy Prolapse surgery
M53.3 Introduction of tension-free vaginal tape Further incontinence surgery
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SUPPLEMENTAL TABLE 2
Office for Population Censuses and Surveys Classification of Interventions and Procedures Version-4 codes used to
identify mesh removal, prolapse surgery, further stress urinary incontinence surgery, and hernia repair (continued)
Code Description (Re-)operation type
M53.6 Introduction of transobturator tape Further incontinence surgery
M52.1 Suprapubic sling operation Further incontinence surgery
M51.1 Abdominoperineal suspension of urethra Further incontinence surgery
M52.3 Colposuspension of neck of bladder Further incontinence surgery
M56.3 Endoscopic injection of inert substance into outlet of
female bladder
Further incontinence surgery
T252 Primary repair of incisional hernia using insert of
prosthetic material
Hernia repair surgery
T253 Primary repair of incisional hernia using sutures Hernia repair surgery
T262 Repair of recurrent incisional hernia using insert of
prosthetic material
Hernia repair surgery
T263 Repair of recurrent incisional hernia using sutures Hernia repair surgery
T259 Unspecified primary repair of incisional hernia Hernia repair surgery
NEC, XXX.
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SUPPLEMENTAL TABLE 3
Cumulative incidences of first surgery for a complication and first further stress incontinence surgery
Characteristic Retropubic colposuspension Mesh sling insertion Autologous sling
Cumulative incidence of first further stress incontinence surgery
At 1 y 1.6 (1.1e2.1) 1.1 (1.1e1.2) 1.8 (1.2e2.6)
At 5 y 5.8 (4.8e6.8) 2.8 (2.7e2.9) 4.2 (3.2e5.4)
At 10 y 7.6 (6.5e8.8) 3.5 (3.3e3.6) 4.8 (3.7e6.2)
Cumulative incidence of first surgery for a complication
At 1 y 3.0 (2.4e3.8) 2.2 (2.1e2.3) 0.9 (0.5e1.6)
At 5 y 11.5 (10.3e12.9) 5.9 (5.8e6.1) 4.9 (3.8e6.2)
At 10 y 15.6 (14.1e17.2) 8.8 (8.6e8.9) 7.8 (6.3e9.4)
Data are presented as percentage (interquartile range).
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SUPPLEMENTAL TABLE 4
Cumulative incidence of first reoperations following first stress urinary incontinence surgery which was not
accompanied by concurrent prolapse repair or hysterectomy, 2006 to 2013
Characteristic Retropubic colposuspension Mesh sling insertion Autologous sling
Number of patients at risk
Total cohort 1449 74,361 1093
At 1 y 1389 72,162 1052
At 5 y 1217 67,787 970
At 10 y 627 23,230 508
Cumulative incidence of any first reoperation
At 1 y 3.9 (2.9e4.9) 2.8 (2.6e2.9) 2.9 (2.1e4.1)
At 5 y 14.4 (12.6e16.2) 6.9 (6.8e7.1) 8.1 (6.5e9.8)
At 10 y 19.9 (17.9e22.2) 9.8 (9.6e10.1) 11.1 (9.3e13.2)
Incidence of different reoperation types at 10 y
Mesh removal 0.0 3.0 0.0
Further stress incontinence surgery 8.6 2.7 5.0
Prolapse surgery 9.3 3.5 4.5
Hernia repair 2.1 0.7 1.7
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SUPPLEMENTAL TABLE 5
Fine-Gray model results: hazard ratios for differences in first reoperation hazard by initial surgery type, including only
first stress urinary incontinence surgeries which were not accompanied by concurrent prolapse repair or
hysterectomy, 2006e2013
Characteristic Subhazard ratio for any first reoperation 95% confidence interval P value
Operation type <.01
Autologous sling 1.00
Retropubic colposuspension 1.91 (1.53e2.38)
















Deprivation quintile,a n (%) .04




5 least deprived 0.92 (0.86e1.00)







Asian or Asian British 0.74 (0.62e0.89)
Black or Black British 0.89 (0.68e1.18)
Other 0.80 (0.65e1.00)
a Ecological measure of the socioeconomic status, based on the national distribution of the Index of Multiple Deprivation ranking of the patient’s local area of residence.
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